tiprankstipranks
Trending News
More News >
Eagle Pharmaceuticals (EGRX)
:EGRX
US Market
Advertisement

Eagle Pharmaceuticals (EGRX) Financial Statements

Compare
212 Followers

Eagle Pharmaceuticals Financial Overview

Eagle Pharmaceuticals's market cap is currently $38.96M. The company's EPS TTM is $; its P/E ratio is ―; Eagle Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Currency in USD

Eagle Pharmaceuticals Earnings and Revenue History

Eagle Pharmaceuticals Debt to Assets

Eagle Pharmaceuticals Cash Flow

Eagle Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis